Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic functionMythili Koneru, David Schaer, Ngozi Monu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Defective adhesion in tumor infiltrating CD8+ T cellsMythili Koneru, Ngozi Monu, David Schaer, et al.
Oncoimmunology|May 8, 2015
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivoMythili Koneru, Terence J Purdon, David Spriggs, et al.
Journal of Translational Medicine|April 19, 2015
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancerMythili Koneru, Roisin O'Cearbhaill, Swati Pendharkar, et al.
Leukemia Research|May 15, 2002
Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J miceJanine Wajchman, William J Simmons, Andrew Klein, et al.
Scientific Reports|September 7, 2017
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironmentOladapo O Yeku, Terence J Purdon, Mythili Koneru, et al.
Experimental Cell Research|August 30, 2008
The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cellsSiang-Yo Lin, Jun Yang, Allen D Everett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasmsWilliam J Simmons, Mythili Koneru, Mani Mohindru, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2025
Real-World Treatment Patterns and Outcomes in Patients With Lenalidomide-Refractory Multiple Myeloma With 1 to 3 Prior Lines: SEER-Medicare DatabaseBinod Dhakal, Jinghua He, Jordan M Schecter, et al.
Pageof 2